^(131)I SPECT/CT用于^(131)I治疗后分化型甲状腺癌研究进展  

Research progresses of^(131)I SPECT/CT in differentiated thyroid cancer after^(131)I treatment

作　　者：席欢 郑容 XI Huan;ZHENG Rong(Department of Nuclear Medicine,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China)

机构地区：[1]国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院核医学科,北京100021

出　　处：《中国医学影像技术》2022年第10期1571-1574,共4页Chinese Journal of Medical Imaging Technology

基　　金：中国癌症基金会“北京希望马拉松”专项基金(LC2020A04)。

摘　　要：对于分化型甲状腺癌(DTC)目前主要采用外科手术切除及术后^(131)I治疗等,^(131)I治疗后DTC复发及转移可影响临床后续治疗及其效果。^(131)I治疗后全身显像(Rx-WBS)为常规影像学监测疗效手段,而^(131)I SPECT/CT将功能代谢与解剖结构信息相结合,可提供更准确、更全面的影像学信息。本文就^(131)I SPECT/CT用于^(131)I治疗DTC后研究进展进行综述。Differentiated thyroid cancer(DTC)is mainly treated with surgical resection and postoperative^(131)I treatment,and the recurrence and metastasis of DTC after^(131)I treatment affect the follow-up clinical treatment and curative effect.Post-therapy whole body scan(Rx-WBS)is a routine imaging monitoring method after^(131)I treatment.^(131)I SPECT/CT can provide accurate and comprehensive imaging information combining functional metabolism with anatomical structure information.The research progresses of^(131)I SPECT/CT for DTC after^(131)I treatment were reviewed in this article.

关 键 词：甲状腺肿瘤 碘同位素 体层摄影术 发射型计算机 单光子 

分 类 号：R736.1[医药卫生—肿瘤] R817.4[医药卫生—临床医学]